Ratings by Cantor Fitzgerald (Imogen Mansfield)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2026 | Sol Gel Technologies Ltd. | SLGL | New Coverage | Overweight (N/A) |
68.30 (64.25) |
-5.93% | Details | |
| 10/9/2026 | Ovid Therapeutics Inc | OVID | New Coverage | Overweight (N/A) |
2.34 (2.15) |
-8.12% | Details | |
| 9/22/2026 | Entera Bio | ENTX | New Coverage | Overweight (N/A) |
2.96 (2.68) |
-9.46% | Details | |
| 9/16/2026 | Q32 Bio Inc. | QTTB | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/21/2026 | Eikon Therapeutics Inc. | EIKN | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2026 | Eikon Therapeutics Inc. | EIKN | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/20/2026 | Candel Therapeutics Inc. | CADL | New Coverage | Overweight (N/A) |
6.37 (8.19) |
28.57% | Details | |
| 3/2/2026 | Eikon Therapeutics Inc. | EIKN | New Coverage | Overweight (N/A) |
13.78 (7.42) |
-46.15% | Details |
